Holen Sie sich die Stockscreener-App
14.30
0.06%
0.005
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$14.30
Offen:
$14.44
24-Stunden-Volumen:
833.94K
Relative Volume:
0.30
Marktkapitalisierung:
$2.85B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.9106
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-10.96%
1M Leistung:
-14.17%
6M Leistung:
-25.83%
1J Leistung:
-43.87%
1-Tages-Spanne:
$14.27
$14.74
1-Wochen-Bereich:
$14.02
$16.29
52-Wochen-Spanne:
$12.16
$27.48
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
14.29 | 2.85B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
482.63 | 173.19B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.68 | 50.55B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.69 | 43.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
291.22 | 40.94B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
237.94 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dental Implants Market Size 2025: Emerging Demands, Trends, - openPR.com
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? - TradingView
Cosmetic Dentistry Market Growth and Future Scope 2025-2032 | - openPR.com
What are the latest earnings results for DENTSPLY SIRONA Inc.Build wealth steadily with smart trading - jammulinksnews.com
What makes DENTSPLY SIRONA Inc. stock price move sharplyMarket-beating returns - jammulinksnews.com
What are DENTSPLY SIRONA Inc. company’s key revenue driversGet timely alerts on top-performing stocks - jammulinksnews.com
DENTSPLY SIRONA Inc. Stock Analysis and ForecastRecord-breaking gains - jammulinksnews.com
What are analysts’ price targets for DENTSPLY SIRONA Inc. in the next 12 monthsAchieve exceptional returns with expert guidance - jammulinksnews.com
What are the technical indicators suggesting about DENTSPLY SIRONA Inc.Free Trend-Following Techniques - jammulinksnews.com
What drives DENTSPLY SIRONA Inc. stock priceConsistently outstanding ROI - jammulinksnews.com
Dentsply Sirona on Track to Beat 2Q Analyst Targets - 富途牛牛
Live Scanner Shows Breakout on DENTSPLY SIRONA Inc.Buy Signal Based on Chart Analysis Confirmed - metal.it
WaveOne Gold turns ten: Dentsply Sirona celebrates a decade of endodontic innovation - Dental Tribune US
Medit's i900 Mobility: A Disruptive Force in Digital Dentistry - AInvest
Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Nasdaq
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Dentsply LawsuitXRAY - ACCESS Newswire
Dental Leaders Unite for Cleft Education - Dentistry Today
Dental Imaging Market Worth US$4.69 billion by 2030 with 7.5% CAGR | MarketsandMarkets™ - PR Newswire UK
Unexpected Trends Reshaping the Endodontic Irrigation Devices - openPR.com
Published on: 2025-07-30 04:32:21 - metal.it
DENTSPLY SIRONA Inc. Enters Reversal Setup in Weekly ChartsPotential Breakout Stock List Published This Week - metal.it
Published on: 2025-07-28 18:31:12 - metal.it
How strong is DENTSPLY SIRONA Inc. company’s balance sheetAccelerated earnings growth - jammulinksnews.com
DENTSPLY SIRONA Inc. Moves Into Bullish Territory Based on MACDTrade Setups With AI Powered Filters Published - beatles.ru
Here's Why Dentsply International (XRAY) is a Strong Momentum Stock - Yahoo Finance
DENTSPLY SIRONA Inc. Company Revenue and Profit Trends: A Deep DiveCapital Protection Trading Strategies Gain Interest - metal.it
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
What is the risk reward ratio of investing in DENTSPLY SIRONA Inc. stockCapitalize on market momentum for maximum gains - jammulinksnews.com
Competitive Positioning of DENTSPLY SIRONA Inc.: Is It Leading or LaggingFree Real-Time Stock Data - metal.it
Should I hold or sell DENTSPLY SIRONA Inc. stock in 2025Outstanding investment returns - jammulinksnews.com
Will DENTSPLY SIRONA Inc. Stock Benefit from AI and Green Energy TrendsInstant Stock Updates - metal.it
Published on: 2025-07-27 16:54:02 - jammulinksnews.com
Published on: 2025-07-27 15:35:17 - jammulinksnews.com
Why DENTSPLY SIRONA Inc. stock attracts strong analyst attentionBreakout Level Watch - Metal.it
Is DENTSPLY SIRONA Inc. a good long term investmentConsistent wealth multiplication - PrintWeekIndia
What analysts say about DENTSPLY SIRONA Inc. stockExplosive wealth accumulation - PrintWeekIndia
Does DENTSPLY SIRONA Inc. stock pay reliable dividendsFree Technical Analysis Support - jammulinksnews.com
What makes DENTSPLY SIRONA Inc. stock attractive to long term investorsTurbocharged investment results - jammulinksnews.com
DENTSPLY SIRONA (NASDAQ:XRAY) adds US$207m to market cap in the past 7 days, though investors from five years ago are still down 59% - Yahoo Finance
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):